1158
173
4
7
294
27
Cat. No. | Product Name | ||
---|---|---|---|
L1300 | PI3K/Akt/mTOR 化合物库 | 420 compounds | |
420 种与PI3K/Akt/mTOR 相关的生物活性小分子化合物的特有集合,用于PI3K/Akt/mTOR 相关研究以及高通量、高内涵筛选; | |||
L3510 | 甲基化化合物库 | 128 compounds | |
128 种甲基化相关的化合物,可以用于高通量和高内涵筛选; | |||
L7300 | 钾通道分子库 | 152 compounds | |
152 种钾通道相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L8710 | 铜死亡化合物库 | 400 compounds | |
TargetMol 铜死亡化合物库集合了 400 种与铜死亡相关的化合物,可以用于铜死亡机制及相关疾病研究 |
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
C0090 |
Mag Beads Streptavidin (1 μm)
链霉亲和素磁珠 (1 μm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0095 |
Magrose Beads Streptavidin (Ultra-suspension)
琼脂糖链霉亲和素磁珠 |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0089 |
Mag Beads Streptavidin (300 nm)
链霉亲和素磁珠 (300 nm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0093 |
Mag Beads Streptavidin (3 μm)
链霉亲和素磁珠 (3 μm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0094 |
Mag Beads Streptavidin (5 μm)
链霉亲和素磁珠 (5 μm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0091 |
Mag Beads Streptavidin (2 μm)
链霉亲和素磁珠 (2 μm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
C0092 |
Mag Beads Streptavidin (2.8 μm)
链霉亲和素磁珠 (2.8 μm) |
Suspension in bottle | 免疫检测、分离蛋白;分离核酸、制备核酸探针;DNA-蛋白质相互作用研究;细胞分选与激活 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T24240 |
K-8012
K8012,K 8012 |
Retinoid Receptor; RAR/RXR | Metabolism |
K-8012 是 N 末端截短的 RXRα 的调节剂,并以 RXRα 依赖性方式提高抗癌活性。 | |||
T11742 |
K-7174
|
IL Receptor; TNF | Apoptosis; Immunology/Inflammation |
K-7174 是一种新型细胞粘附抑制剂, 抑制由 IL-1β 或 TNF-α 诱导的血管细胞粘附分子 1 (VCAM-1) 的表达。 | |||
T15639 |
K-756
|
PARP; Wnt/beta-catenin | Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; Stem Cells |
K-756 是一种直接的 tankyrase(TNKS) 选择性抑制剂,对 TNKS1和 TNKS2的 ADP-核糖基化活性有抑制作用,IC50分别为 31 和 36 nM。 | |||
T8936 |
Proteinase K
proteinase K for tritirachium album,Protease K,蛋白酶 K |
Others | Others |
Proteinase K (proteinase K for tritirachium album) 是一种非特异性丝氨酸蛋白酶,可用于蛋白消化。它在有 SDS 或尿素存在的情况下,在很大 pH 值 (4-12)、盐浓度和温度单位内均有活性。 | |||
T11742L |
K-7174 dihydrochloride
K7174 2HCl,K-7174 2HCl,K 7174 2HCl |
Proteasome | Proteases/Proteasome; Ubiquitination |
K-7174 dihydrochloride 是具有口服活性的 proteasome 和 GATA 抑制剂,抑制白细胞粘附和炎症因子表达,抑制神经元变性,诱导细胞凋亡。K-7174 dihydrochloride 具有抗肿瘤活性,可用于研究神经精神系统性红斑狼疮和认知功能障碍。 | |||
T9954 |
K-975
|
Others | Others |
K-975是一种高选择性的具有口服活性的TEAD 抑制剂,可有效抑制TEAD 和YAP1/TAZ 之间的蛋白质-蛋白质相互作用。 | |||
T11733 |
K-604 dihydrochloride
|
Acyltransferase | Metabolism |
K-604 dihydrochloride 是酰基辅酶 A:胆固醇酰基转移酶 1 的选择性抑制剂,IC50为 0.45±0.06 μM。 | |||
T27706 |
K-111
BM 170744,K111,K 111,BM170744,BM-170744 |
PPAR | DNA Damage/DNA Repair; Metabolism |
K-111 (BM-170744) 是一种可口服的过氧化物酶体增殖物激活受体 (PPAR)-α 激动剂和胰岛素增强剂,可用于研究肥胖型糖尿病和代谢综合征。 | |||
T11734 |
K-80003
TX-803 |
Akt; RAR/RXR | Cytoskeletal Signaling; Metabolism; PI3K/Akt/mTOR signaling |
K-80003(TX-803) 是一种有效的类视黄醇 X 受体α调节剂,对 tRXRα 依赖性的 Akt 激活和肿瘤细胞生长有抑制作用。 | |||
T6777 |
Bay K 8644
(±)-BAY-K-8644,SQ 28,873 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Bay K 8644 (SQ 28,873)是一种二氢吡啶化合物,是一种选择性的 L 型 Ca2+ 通道激活剂,IC50 为 17.3 nM。它通过增加通道的开放时间来增加通过肌膜 Ca2+通道的 Ca2+流入。 | |||
TQ0145 |
(R)-(+)-Bay-K-8644
(R)-(+)-Bay K 8644 |
Calcium Channel; PPAR | DNA Damage/DNA Repair; Membrane transporter/Ion channel; Metabolism |
(R)-(+)-Bay-K-8644 是一种 Ca2+ 通道抑制剂,也能抑制 Ba2+电流 (IBa),诱导猫的中枢性呼吸抑制,通过竞争性拮抗血栓素 A2-前列腺素 H2 受体抑制血小板活化。 | |||
TP2009L |
K 41498 aceate
|
CRFR | GPCR/G Protein |
K41498 acetate 是 antisauvagine-30 的类似物,可抑制 suvagine 刺激的 cAMP 在表达 hCRF2α 和 hCRF2β 的细胞中的积累。 K41498 acetate 是一种有效且高度选择性的 CRF2 受体拮抗剂,对人 CRF2α、CRF2β 和 CRF1 受体的 Ki 值分别为 0.66 nM、0.62 nM 和 425 nM。 | |||
TQ0144 |
(S)-(-)-Bay-K-8644
(S)-(-)-Bay K 8644 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
(S)-(-)-Bay-K-8644 ((S)-(-)-Bay K 8644) 是 L 型 Ca2+ 通道的激动剂,可激活 Ba2+ 电流,其EC50 为 32 nM。 | |||
T29087 |
VA-K-14 hydrochloride
VAK14 Hydrochloride,VA K 14 HCl,VA-K-14 HCl,VAK14 HCl |
TSH Receptor | GPCR/G Protein |
VA-K-14 hydrochloride(VAK14 HCl)是一种选择性促甲状腺激素受体 (TSHR) 拮抗剂 (IC50= 12.3 μM),对GD患者血清和单克隆刺激TSHR抗体对TSHR的刺激有抑制作用,可消除 TSHR 信号传导。 | |||
T5469 |
K-Ras-IN-1
|
Raf; Ras | GPCR/G Protein; MAPK |
K-Ras-IN-1 是K-Ras 抑制剂。K-Ras-IN-1 能与 K-Ras (WT)、K-Ras (G12D)、K-Ras (G12V) 和 H-Ras 结合。它对胰腺癌、结肠癌和肺癌的具潜在的研究价值。 | |||
T11738 |
K-Ras G12C-IN-4
|
Ras | GPCR/G Protein; MAPK |
K-Ras G12C-IN-4 是一种 KRAS G12C 共价抑制剂。 | |||
T4618 |
BGG463
K 0859 |
Bcr-Abl; CDK | Angiogenesis; Cell Cycle/Checkpoint; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
BGG463 (K 0859) 是一种具有口服活性的 II 型 CDK2的抑制剂,可抑制 c-ABL-T334I、BCR-ABL 和 BCR-ABL-T315I 变体,IC50分别为 0.25 μM、0.09 μM 和 0.590 μM。 | |||
T6556 |
K-Ras(G12C) inhibitor 9
|
Raf | MAPK |
K-Ras(G12C) inhibitor 9 是致癌 K-Ras(G12C) 的变构抑制剂。 | |||
T3725 |
K-Ras(G12C) Inhibitor 6
|
Raf | MAPK |
KRas(G12C) inhibitor 6 是一种变构的,选择性的 K-Ras(G12C)抑制剂。 | |||
T1914 |
K02288
K 02288 |
ALK; TGF-beta/Smad | Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors |
K 02288是骨形态发生蛋白 (BMP) I 型受体抑制剂,能够抑制 ALK1 (IC50:1.8nM)、ALK2 (IC50:1.1nM)、ALK6 (IC50:6.4nM)。对 ALK3 和 ALK6 的抑制稍弱,IC50在 5-34 nM 之间。 | |||
T6555 |
K-Ras(G12C) inhibitor 12
|
Apoptosis; Raf; Ras | Apoptosis; GPCR/G Protein; MAPK |
K-Ras(G12C) inhibitor 12是一种K-Ras(G12C)抑制剂,作用于H1792细胞,EC50为0.32 μM。 | |||
T8659 |
K-Ras-PDEδ-IN-1
|
PDE | Metabolism |
K-Ras-PDEδ-IN-1 是新型的 K-Ras-PDEδ 抑制剂,它能够以低纳摩尔Kd8 nM 与 PDEδ 的法尼基结合袋竞争性结合。 | |||
T24239 |
K201
K-201,JTV 519,JTV-519,K 201 |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
K201 (JTV-519) 是一种 Ca2+ 依赖性阻滞剂,通过稳定兰尼碱受体来防止缺血性心脏和骨骼肌 (SkM) 中的肌质网异常 Ca(2+) 泄漏。 | |||
T27704 |
K00135
K-00135,Imidazol[1,2-b]pyridazine 1,K 00135,IMIDAZOPYRIDAZIN 1 |
Pim | Chromatin/Epigenetic; JAK/STAT signaling |
K00135 (IMIDAZOPYRIDAZIN 1) 是 Pim 激酶的选择性抑制剂,可用于胃癌和抗白血病治疗的研究。 | |||
TQ0138 |
K145 hydrochloride
K145盐酸盐 |
Apoptosis; S1P Receptor | Apoptosis; GPCR/G Protein |
K145 hydrochloride 是选择性的,底物竞争性的和口服有效的SphK2抑制剂,IC50为 4.3 µM,Ki 为 6.4 µM。它可诱导细胞凋亡,显示出强大的抗肿瘤活性。 | |||
T15641 |
K777
APC-3316 |
P450; Cysteine Protease; CCR | Immunology/Inflammation; Metabolism; Microbiology/Virology; Proteases/Proteasome |
K777 是有效的,具有口服活性的,不可逆的半胱氨酸蛋白酶 (cysteine protease) 抑制剂。K777是有效的 CYP3A4 抑制剂(IC50= 60 nM)。K777也是选择性的 CCR4 拮抗剂,显示出强的趋化性抑制作用。K777 对 Cruzain(克鲁斯锥虫的主要半胱氨酸蛋白酶)和组织蛋白酶 B 和 L 具有不可逆的抑制作用。K777 通过靶向组织蛋白酶介导的细胞进入,显示出广谱的抗病毒作用。K777 抑制 EBOV 和 SARS-CoV 病毒的进入,IC50 值分别为 0.87 nM 和 0.68 nM。 | |||
T6866 |
AUZ 454
K03861 |
CDK | Cell Cycle/Checkpoint |
AUZ 454 (K03861) 是一种 II 型 CDK2 抑制剂,Kd 值是 8.2 nM。它对 CDK2(WT)、CDK2(C118L)、CDK2(A144C) 和 CDK2(C118L/A144C) 的 Kd 分别为 50 nM、18.6 nM、15.4 nM 和 9.7 nM。 | |||
T3120 |
K858 (Racemic)
K858 Racemic,K858 |
Apoptosis; Kinesin | Apoptosis; Cytoskeletal Signaling |
K858 Racemic (K858) 是一种选择性有丝分裂驱动蛋白 Eg5 抑制剂,以 ATP 非竞争性方式起作用,IC50值为 1.3 μM。 | |||
TP1682L |
Abz-FR-K(Dnp)-P-OH acetate
Abz-FR-K(Dnp)-P-OH acetate (500799-61-1 free base) |
Others | Others |
Abz-FR-K(Dnp)-P-OH acetate(500799-61-1 free base) 是一种出色的血管紧张素 I 转换酶 (ACE) 底物,Km 值为 4.0 μM,kcat 值为 210s-1。 | |||
T27710 |
K6PC-5
K6PC5,K6PC 5 |
S1P Receptor | GPCR/G Protein |
K6PC-5 is a ceramide derivative that acts as an activator of sphingosine kinase 1 (SPHK1), inducing a swift and temporary rise in intracellular calcium levels. With its potential applications in skin diseases associated with abnormal keratinocyte function, as well as in studies on neurodegeneration and virus infection, K6PC-5 presents a promising compound for research purposes. | |||
T33581 |
Nafetolol
K 5407,K-5407 |
Others | Others |
Nafetolol (K 5407) 是一种生化试剂,可用于合成其他化合物。 | |||
T125462 |
Gnetifolin K
GnetifolinK |
||
Gnetifolin K (GnetifolinK) 是一种来自 Gnetum parvifolium 的新型二苯乙烯二葡萄糖苷,具有潜在的神经保护活性,可用于研究DNA损伤。 | |||
T36100 |
K-TMZ
|
Others | Others |
K-TMZ is a DNA alkylating agent. It increases the concentration of O6-methylated deoxyguanosine in U87 glioblastoma multiforme (GBM) cells in a concentration-dependent manner. K-TMZ reduces cell viability of GBM cell lines lacking (IC50s = 18-44 μM) or expressing O6-methylguanine DNA methyltransferase (MGMT; IC50s = 115-240 μM). K-TMZ can cross the blood-brain barrier and increases survival in a Br23c mouse xenograft model of GBM when administered at a dose of 14.9 mg/kg. | |||
T9418 |
NEUROPEPTIDE K
|
Others | Others |
NEUROPEPTIDE K 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T9418,CAS号为 106441-70-7。 | |||
T69760 |
TT-10
TAZ-K |
YAP | Stem Cells |
TT-10 (TAZ-K) 作为YES相关蛋白(YAP)-转录增强因子结构域(TEAD)活性的激活剂,适用于心肌细胞丢失伴随心脏病研究。 | |||
T70949 |
K-8986
|
Others | Others |
K-8986 is a novel h1-receptor antagonist | |||
T27832 |
Lifibrol
U 83860,K-12148,K-12.148,U-83860,K12148 |
Lipid | Metabolism |
Lifibrol (U-83860) 是一种胆固醇合成抑制剂。Lifibrol 具有抗胆固醇和降血脂的作用,可促进高胆固醇血症和混合型高脂血症患者体内低密度脂蛋白载脂蛋白 B-100 的转化。 | |||
T40537 |
Ibuprofen Impurity K
|
Others | Others |
Ibuprofen Impurity K is a compound that serves as an impurity in Ibuprofen. Ibuprofen itself is an anti-inflammatory inhibitor specifically designed to target COX-1 and COX-2. It exhibits inhibitory activity with IC50 values of 13 μM and 370 μM for COX-1 and COX-2, respectively. | |||
T8882 |
Vodobatinib
K-0706 |
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Vodobatinib (K-0706) 是第三代具有口服活性的Bcr-Abl1酪氨酸激酶抑制剂,IC50=7 nM,对大多数 BCR-ABL1 点突变体具有活性,但对 BCR-ABL1T315I 无活性。它可用于研究慢性粒细胞白血病 (CML)。 | |||
T25682 |
Leucinostatin K
Leucinostatin-K |
Others | Others |
Leucinostatin K is a new peptide antibiotic from Paecilomyces lilacinus. | |||
T32354 |
K 8409
K8409,K-8409 |
Others | Others |
K 8409 is a bioactive chemical. | |||
T32349 |
K 2604
K-2604,K2604 |
Others | Others |
K 2604 is a bioactive chemical. | |||
T32352 |
K 486
K486,K-486,K 486, CARBANILIC ACID |
Others | Others |
K 486 is a bioactive chemical. | |||
T22886 |
K 579
|
Others | Others |
K 579 is a dipeptidyl peptidase IV inhibitor. | |||
T24215 |
JS-K
JSK,JS K |
Others | Others |
JS-K is a Nitric oxide donor. It has antiproliferative activity. | |||
T21950 |
K 00546
|
Others | Others |
K00546 是一种有效的细胞周期蛋白依赖性激酶CDK1和CDK2抑制剂,对CDK1/cyclin B 和CDK2/cyclin A 的IC50分别为 0.6 nM 和 0.5 nM。K00546 也是一种有效的 CDC2 样激酶 1 (CLK1) 和CLK3抑制剂,IC50分别为 8.9 nM 和 29.2 nM。 | |||
T32345 |
K 12425
K-12425,K12425 |
Others | Others |
K 12425 is a bioactive chemical. | |||
T25564 |
K-13
K-13 (Ace inhib) |
Others | Others |
K-13 is used as an ACE inhibitor produced by Micromonospora halophytics subsp. exilisia K-13. | |||
T32351 |
K 309
|
Others | Others |
K 309 is a bioactive chemical. | |||
T32350 |
K 308
K-308,K308 |
Others | Others |
K 308 is a bioactive chemical. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S2309 |
Hosenkoside K
凤仙萜四醇苷K,(+)-Hosenkoside K |
Others | Others |
Hosenkoside K 是一种糖苷,分离自凤仙花种子。 | |||
T8200 |
Ginkgolide K
银杏内酯 K,银杏内酯K |
AMPK; Autophagy | Autophagy; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
Ginkgolide K 是从银杏中分离得到的一种二萜类天然产物,有神经保护活性,可通过 AMPK/mTOR/ULK1信号通路诱导保护性自噬。 | |||
T19603 |
Vitamin K
Kephton,维生素K,Vitamin K1(20) |
Endogenous Metabolite | Metabolism |
Vitamin K (Kephton) 具有凝血作用,对凝血因子、基质-Gla 蛋白和骨钙素很重要。 | |||
T3811 |
Ginsenoside C-K
20(S)-人参皂苷 C-K,Ginsenoside compound K,Ginsenoside K,人参皂苷 C-K |
P450; cell cycle arrest; COX; NO Synthase | Cell Cycle/Checkpoint; Immunology/Inflammation; Metabolism; Neuroscience |
Ginsenoside C-K (Ginsenoside K) 是 Ginsenoside Rb1 的细菌代谢物,可通过抑制诱生型一氧化氮合酶和COX-2来发挥抗炎作用。它在人肝微粒体中抑制CYP2C9和CYP2A6活性,IC50分别为 32.0±3.6 和 63.6±4.2 μM。 | |||
T0449 |
Menadione
维生素K3,Vitamin K3,甲萘醌 |
Thrombin; Endogenous Metabolite | Metabolism; Proteases/Proteasome |
Menadione (Vitamin K3) 是合成的萘醌,能够在体内转化成活性维生素 K2。 | |||
T2570 |
Vitamin K4
维生素K4,维生素 K4,Kapilin,Menadiol Diacetate,acetomenaphthone |
Apoptosis; Endogenous Metabolite | Apoptosis; Metabolism |
Vitamin K4 (Menadiol Diacetate) 是一种维生素药物,用于治疗因缺乏 VK4 引起的凝血障碍。 | |||
TN5268 |
Yadanzioside K
|
Others | Others |
Yadanzioside K is a natural product from Brucea javanica. | |||
TN2266 |
Terrestrosin K
|
Others | Others |
Terrestrosin K is a natural product | |||
TN1843 |
Kushenol K
|
PDE; HSV | Metabolism; Microbiology/Virology |
Kushenol K is a potent and Selective Inhibitor of cGMP Phosphodiesterase 5, it also has inhibitory effects on diacylglycerol acyltransferase (DGAT). Kushenol K shows weak antiviral activity against Herpes simplex virus types I and II. | |||
TN1388 |
Angelol K
|
Others | Others |
Angelol K shows significant activity on human platelet aggregation. | |||
TN1945 |
Momordicoside K
|
Others | Others |
Momordicoside K has antidiabetic activity. | |||
T75675 |
Nepasaikosaponin K
|
Antiviral | Immunology/Inflammation |
Nepasaikosaponin K 是一种从柴胡根中分离出来小分子化合物,具有抗流感和抗病毒活性,可用于研究病毒感染。 | |||
TN4971 |
Sculponeatin K
|
Others | Others |
Sculponeatin K是一种天然产物,属于唇形科香茶菜属,其产品编号为 TN4971,CAS号为 477529-70-7。Sculponeatin K可用作对照参考。 | |||
TN5664 |
Epimedonin K
|
||
Epimedonin K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5664,CAS号为 2222285-85-8。 | |||
TN6589 |
Grossamide K
|
||
Grossamide K exerts a particularly strong anti-melanogenic activity on the cells without high cell toxicity. | |||
TN5465 |
Derrisisoflavone K
|
||
Derrisisoflavone K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5465,CAS号为 2172624-68-7。 | |||
TN3646 |
Chlorovaltrate K
|
Others | Others |
Chlorovaltrate K shows moderate cytotoxicity against lung adenocarcinoma (A 549), metastatic prostate cancer (PC-3M), colon cancer (HCT-8) and hepatoma (Bel 7402) cell lines with IC50 values of 0.89-9.76 uM. | |||
TN4942 |
Sanggenone K
|
Others | Others |
Sanggenone K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4942,CAS号为 86450-77-3。 | |||
TN4481 |
Macrocarpal K
|
Others | Others |
Macrocarpal K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4481,CAS号为 218290-59-6。 | |||
T15638 |
K-252c
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
K-252c is a staurosporine analog isolated from Nocardiopsis sp. and is a cell-permeable PKC inhibitor (IC50: 2.45 μM). K-252c also inhibits β-lactamase, chymotrypsin, and malate dehydrogenase. K-252c causes apoptosis in human chronic myelogenous leukemia cancer cells. | |||
TN4362 |
k-Strophanthoside
|
Others | Others |
k-Strophanthoside 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4362,CAS号为 33279-57-1。 | |||
TN4805 |
Platycoside K
|
Others | Others |
Platycoside K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4805,CAS号为 899447-64-4。 | |||
TN4589 |
Mulberrofuran K
|
Others | Others |
Mulberrofuran K shows potent anti-oxidation activities. | |||
TN3971 |
Epimedin K
|
Others | Others |
Epimedin K is a natural product from Epimedium koreanum NAKAI (Berberidaceae). | |||
TN5846 |
Mumeose K
|
||
Mumeose K 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN5846,CAS号为 2132384-01-9。 | |||
T15637 |
K-252b
|
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
K-252b is an indolocarbazole isolated from the actinomycete Nocardiopsis and is a PKC inhibitor. K-252b can be used to inhibit extracellular kinases of cells in culture because it can’t pass through the cell membrane freely. | |||
TN3105 |
5-Dehydroxyparatocarpin K
|
Others | Others |
5-Dehydroxyparatocarpin K是一种天然产物,属于豆科补骨脂属,其产品编号为 TN3105,CAS号为 124858-37-3。5-Dehydroxyparatocarpin K可用作对照参考。 | |||
T25563 |
K 41
K-41,K41,Antibiotic K-41A,37454 RP,Antibiotic A 32887 |
Others | Others |
K 41 is a polycyclic polyether antibiotic from Streptomyces hygroscopicus. | |||
T15636 |
K-252a
Antibiotic K 252a,Antibiotic SF 2370,SF2370 |
Others | Others |
K-252a is a staurosporine analog isolated from Nocardiopsis sp. soil fungi. K-252a inhibits protein kinase (IC50: 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively). | |||
TN4103 |
Ganoderic acid K
|
||
Ganoderic acid K is an angiotensin-converting enzyme inhibitor. It has anti-tumor, and anti-inflammatory activities. | |||
TN1631 |
Eupalinolide K
[3AR-[3AR*,4R*(E),6E,9S*,10E,11AR*]]-4-羟基-2-甲基-2-丁烯酸 2,3,3A,4,5,8,9,11A-八氢-9-羟基-6,10-二甲基-3-亚甲基-2-氧代环癸五烯并[B]呋喃-4-基酯,野马追内酯 K,野马追内酯K |
STAT | JAK/STAT signaling; Stem Cells |
Eupalinolide K 是来自野马追的一种倍半萜内酯,是 STAT3抑制剂,可作为迈克尔反应受体。 | |||
TN1763 |
Ilexsaponin B3
冬青苷K,Ilexoside K |
Others | Others |
Ilexoside K is a natural product from Ilex pubescens. | |||
T2336 |
Vitamin K2
Menatetrenone,四烯甲萘醌 |
Endogenous Metabolite | Metabolism |
Vitamin K2 (Menatetrenone) 是内源性代谢产物的一种。 | |||
T20754 |
Deltamethrin
Butoss,RU-22974,Esbecythrin,溴氰菊酯,K-Othrin,Decamethrin,RU 22974 |
Others | Others |
Deltamethrin (RU 22974) 是一种具有神经毒性的拟除虫菊酯杀虫剂,在大鼠中能够产生一系列可逆的运动症状(如包括后肢僵硬、舞蹈性关节炎)。 | |||
T1719 |
Bufalin
|
ATPase | Membrane transporter/Ion channel |
Bufalin 是蟾酥中的一种成分,是Na+/K+-ATPase 抑制剂,具有抗肿瘤活性,可与其基 α1、α2 和 α3 结合,Kd 值分别为 42.5、45 和 40 nM。 | |||
T41124 |
Kizuta saponin K11
|
Others | Others |
Kizuta saponin K11 is a saponin derived from Kalopanax pictum var. maximowiczii leaves, which is a widely used Korean medicinal plant. | |||
T2913 |
Schisantherin A
五味子酯甲,Schisanwilsonin H,Gomisin-C,Wuweizi ester-A,Schizantherin-A,Arisanschinin K |
NF-κB | NF-κB |
Schisantherin A (Wuweizi ester-A) 是一种利用 IκBα 降解,抑制p65-NF-κB 易位进入细胞核的木脂素。 | |||
T20198 |
Potassium gluconate
Kalium-beta,Kalium Gluconate,Kaon elixir,Kaon,Potassium D-gluconate,HSDB 3165,K-Iao |
Endogenous Metabolite; Antifungal | Metabolism; Microbiology/Virology |
Potassium gluconate (Potassium D-gluconate) 是一种具有口服活性和螯合性质的氧化型羧酸,具有杀菌活性。 | |||
T1075 |
Vitamin K1
Phylloquinone,维生素K1,叶绿醌,Phytomenadione,Phytonadione,Phyllohydroquinone |
Others; Endogenous Metabolite | Metabolism; Others |
Vitamin K1 (Phylloquinone)是天然存在的维生素。Vitamin K1是血液凝固,骨和血管代谢所必须的。 | |||
T4898 |
Potassium 1-carboxyvinyl hydrogenphosphate
PEP-K,磷酸烯醇丙酮酸单钾盐,Phospho(enol)pyruvic acid monopotassium |
Others; Endogenous Metabolite | Metabolism; Others |
Potassium 1-carboxyvinyl hydrogenphosphate (PEP-K) 是内源性代谢产物的一种。 | |||
T7106 |
Menaquinone-4
四烯甲萘醌,Vitamin K2,Menaquinone K4 |
Others; Endogenous Metabolite | Metabolism; Others |
Menaquinone-4 (Vitamin K2) 是维生素 K 的一种,用作止血剂,有潜力用于骨质疏松的研究。 | |||
TJP2872 |
Acevaltrate
Acevaltratum,乙酰缬草三酯,Acetoxyvaltrate |
ATPase; Others | Membrane transporter/Ion channel; Others |
Acevaltrate (Acevaltratum) 对人小细胞肺癌细胞系 GLC(4) 和人结肠直肠癌细胞系 COLO 320 具有高细胞毒性,IC50 值为 1-6 uM。它抑制大鼠肾和脑半球中 Na+/K+-ATP 酶活性,IC50分别为 22.8 和 42.3 μM。 | |||
T7050 |
alpha-Tocopherolquinone
托可醌,Metarene |
Antioxidant | oxidation-reduction |
alpha-Tocopherolquinone (Metarene) 会下调线粒体的呼吸活动。在还原为生育酚氢醌后,它还显示出抗氧化活性。在大鼠缺氧期间,已发现它的水平升高。 | |||
TN7565 |
Notoginsenoside K
|
Others | Others |
Notoginsenoside K 是一种三萜类天然产物,可以作为参考标准。 | |||
T79936 |
Forrestiacids K
|
ATP Citrate Lyase | Metabolism |
Forrestiacids K, 萜类化合物,源自Pseudotsuga forrestii,作为ATP-citrate lyase (ACL) 的抑制剂。 | |||
T83110 |
Angulatin K
|
||
Angulatin K为Celastrus angulatus根皮中发现的天然倍半萜多元醇酯。 | |||
T75480 |
Guignardone K
|
Others | Others |
Guignardone K,一种二萜化合物,从内生真菌(Guignardia sp.)的固体培养物中分离出来,具有抗真菌活性。 | |||
T81701 |
Nardoguaianone K
10-epi-Nardoguaianone J |
||
Nardoguaianone K,一种从Nardostachys chinensis根中分离得到的愈创木脂类化合物,用于胰腺癌研究。 | |||
T79998 |
Celosin K
|
Apoptosis | Apoptosis |
Celosin K,一种可从Semen Celosiae的种子中分离得到的化合物,有效抑制t-BHP引起的神经元损伤。该化合物通过抑制氧化应激、细胞凋亡和自噬过程发挥作用。 | |||
T81972 |
Kuwanon K
|
||
Kuwanon K为从Morus Lhou分离得到的天然化合物。 | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06056 |
KRAS Protein, Human, Recombinant (G12D, His)
KRAS1,K-RAS4B,Kirsten rat sarcoma... |
Human | E. coli |
KRAS Protein, Human, Recombinant (G12D, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22 kDa and the accession number is P01116-2. | |||
TMPY-04113 |
KRAS Protein,Human,Recombinant(G12D & Q61H, His)
Kirsten rat sarcoma viral oncogene homolog,K |
Human | E. coli |
KRAS Protein,Human,Recombinant(G12D & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2. | |||
TMPY-04116 |
KRAS Protein,Human,Recombinant(G12C & Q61H, His)
NS,CFC2,K-RAS4B,C-K-RAS,KRAS2, |
Human | E. coli |
KRAS Protein,Human,Recombinant(G12C & Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 23.3 kDa and the accession number is P01116-2. | |||
TMPY-01888 |
KRAS Protein,Human, Recombinant (Q61H, His)
KRAS2,C-K-RAS,Kirsten rat sarcoma... |
Human | E. coli |
KRAS Protein,Human, Recombinant (Q61H, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 22.5 kDa and the accession number is P01116-2. | |||
TMPY-06567 |
Granzyme K/GZMK Protein, Human, Recombinant (His)
granzyme K,TRYP2 |
Human | HEK293 Cells |
Granzyme K/GZMK Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 27.56 kDa and the accession number is NP_002095.1. | |||
TMPH-02689 |
Granzyme K/GZMK Protein, Mouse, Recombinant (His & Myc)
Gzmk,Granzyme K |
Mouse | E. coli |
Granzyme K/GZMK Protein, Mouse, Recombinant (His & Myc) is expressed in E. coli with N-terminal 10xHis tag and C-terminal Myc tag. The predicted molecular weight is 33.9 kDa. Accession number: O35205 | |||
TMPY-01050 |
Cadherin 6/CDH6 Protein, Human, Recombinant (His)
CAD6,cadherin 6, type 2, K-cadherin (fetal k |
Human | HEK293 Cells |
Cadherin 6/CDH6 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 68 kDa and the accession number is P55285-1. | |||
TMPH-03262 |
Cathepsin K Protein, Rat, Recombinant (His)
CTSO,CTSO2,Cathepsin O2,Cathepsin X,Cathepsin O,CTSK |
Rat | E. coli |
Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen. | |||
TMPH-02565 |
Cathepsin K Protein, Mouse, Recombinant (His)
Cathepsin O,Cathepsin K,CTSK,Cathepsin O2,... |
Mouse | E. coli |
Thiol protease involved in osteoclastic bone resorption. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen. Cathepsin K Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 27.4 kDa and the accession number is P... | |||
TMPH-01061 |
Cathepsin K Protein, Human, Recombinant (His)
CTSO2,Cathepsin X,Cathepsin O2,CTSK,Cathepsin O,Cat... |
Human | E. coli |
Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen. Cathepsin K Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The pre... | |||
TMPY-05004 |
FGF-4 Protein, Human, Recombinant
HST-1,KFGF,fibroblast growth factor 4,HSTF1,K |
Human | E. coli |
FGF (fibroblast growth factor) signalling is known to be required for many aspects of mesoderm formation and patterning during Xenopus development and has been implicated in regulating genes required for the specification of both blood and skeletal muscle lineages. Fibroblast growth factor 4 (FGF4) signaling induces differentiation from embryonic stem cells (ESCs) via the phosphorylation of downstream molecules such as mitogen-activated protein kinase/extracellular signal-related kinase (MEK) a... | |||
TMPY-05414 |
NKG2D/CD314 Protein, Mouse, Recombinant (hFc)
D6H12S2489E,NKG2-D,killer cell lectin-li |
Mouse | Baculovirus Insect Cells |
NKG2D/CD314 Protein, Mouse, Recombinant (hFc) is expressed in Baculovirus insect cells with hFc tag. The predicted molecular weight is 44.9 kDa and the accession number is O54709-2. | |||
TMPY-03376 |
NKG2D/CD314 Protein, Rhesus, Recombinant (aa 78-216, His)
NKG2-D,NKG2D,KLRK1,k... |
Rhesus | Baculovirus Insect Cells |
NKG2D/CD314 Protein, Rhesus, Recombinant (aa 78-216, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 18.3 kDa and the accession number is P61252. | |||
TMPY-03256 |
NKG2D/CD314 Protein, Human, Recombinant (aa 78-216, His)
KLR,killer cell lectin-like recep... |
Human | Baculovirus Insect Cells |
NKG2D/CD314 Protein, Human, Recombinant (aa 78-216, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 18.4 kDa and the accession number is P26718-1. | |||
TMPY-00467 |
NKG2D/CD314 Protein, Human, Recombinant (hFc)
D12S2489E,killer cell lectin-like receptor... |
Human | CHO Cells |
NKG2D/CD314 Protein, Human, Recombinant (hFc) is expressed in CHO mammalian cells with hFc tag. The predicted molecular weight is 46.5 kDa and the accession number is A0A024RAP8. | |||
TMPH-02699 |
H2-K1 Protein, Mouse, Recombinant (GST)
H-2 class I histocompatibility antigen, K-D alpha c... |
Mouse | E. coli |
Involved in the presentation of foreign antigens to the immune system. | |||
TMPK-01510 |
HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)
NS,NS3,KRAS2,RASK2,MHC,RALD,K-Ras... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01463 |
HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Monomer Protein, Human, MHC (His & Avi)
C-K-RAS,KI-RAS,KRAS1,K-R... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01429 |
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
MHC,K-Ras 2,NS,K-RAS4A,KRAS,NS3,<... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01518 |
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)
MHC,NS,KRAS1,K-RAS2A,GTPase Kras,... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01527 |
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)
NS,RALD,C-K-RAS,RASK2,K-RAS2B, |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01408 |
HLA-A*02:01&B2M&KRAS G12V (KLVVVGAVGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RALD,KRAS1,KRAS2,K-RAS2B,CFC2,NS3... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01433 |
HLA-A*11:01&B2M&KRAS G12C (VVVGACGVGK) Tetramer Protein, Human, MHC (His & Avi)
GTPase Kras,NS3,K-Ras 2,K-RAS2B,R... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01401 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
MHC,CFC2,K-Ras 2,RALD,K-RAS4A,NS,RASK<... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01488 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi)
K-RAS4A,MHC,GTPase Kras,K-Ras 2,<... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01458 |
HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi)
K-Ras 2,GTPase Kras,KRAS2,MHC, |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01451 |
HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)
NS3,K-RAS4A,K-Ras 2,NS,KRAS1,RAS<... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01529 |
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi)
K-RAS4A,KRAS1,MHC,K-RAS2B,CFC2,GT... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-00596 |
SECTM1 Protein, Human, Recombinant (hFc)
SECTM1,K-12 |
Human | HEK293 Cells |
SECTM1 is a T/NK cell "co-stimulatory" molecule that is expressed in the peripheral blood by neutrophils and monocytes.Human monocytic cells also displayed a pronounced negative regulation of SECTM1 mRNA expression by LPS, while at the protein level SECTM1 expression was also shown to be regulated by IFN and LPS. This tight regulation of SECTM1 gene expression and rapid upregulation highlights its relevance in the innate immune response. | |||
TMPK-01489 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Tetramer Protein, Human, MHC (His & Avi)
K-RAS2A,NS3,KRAS1,KRAS2,MHC,NS, |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01526 |
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, Human, MHC (His & Avi)
KRAS,NS3,GTPase Kras,RASK2,K<... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01490 |
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi)
K-RAS2A,GTPase Kras,K-Ras 2,RALD,... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01453 |
HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
RASK2,CFC2,K-Ras 2,NS3,GTPase Kra... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01464 |
HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
C-K-RAS,K-RAS4A,GTPase Kras,K... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01537 |
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
K-RAS4A,NS,C-K-RAS,RALD,GTPase Kr... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01536 |
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
NS3,MHC,KRAS,RALD,CFC2,K-RAS2B,GTPase ... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01400 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
NS,KRAS1,RALD,K-RAS2A,K-RAS2B, |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01457 |
HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
K-Ras 2,CFC2,RALD,MHC,KRAS,K-RAS4... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01471 |
HLA-A*11:01&B2M&KRAS WT (VVVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), FITC-Labeled
CFC2,KRAS,K-RAS4B,MHC,K-RAS2B, |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01431 |
HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer Protein, Human, MHC (His & Avi)
RALD,C-K-RAS,MHC,K-RAS2A,GTPase K... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01407 |
HLA-A*02:01&B2M&KRAS WT (KLVVVGAGGV) Monomer Protein, Human, MHC (His & Avi), Biotinylated
KRAS2,RALD,C-K-RAS,NS3,MHC,CFC2,K... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01439 |
HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Tetramer Protein, Human, MHC (His & Avi), PE-Labeled
KRAS,GTPase Kras,K-RAS2A,K |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPY-00972 |
FGFR2 Protein, Human, Recombinant (His & hFc)
K-SAM,TK14,BBDS,fibroblast growth factor r... |
Human | HEK293 Cells |
FGFR2 Protein, Human, Recombinant (His & hFc) is expressed in HEK293 mammalian cells with His and hFc tag. The predicted molecular weight is 67.6 kDa and the accession number is P21802-1. | |||
TMPY-00423 |
FGFR2 Protein, Human, Recombinant (alpha IIIb, hFc)
BFR-1,KGFR,TK25,JWS,ECT1,K-SAM,FG... |
Human | HEK293 Cells |
FGFR2 Protein, Human, Recombinant (alpha IIIb, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 66.3 kDa and the accession number is P21802-17. | |||
TMPK-01404 |
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi), Biotinylated
NS,KRAS,KRAS1,KRAS2,MHC,RALD,... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01434 |
HLA-A*11:01&B2M&KRAS G12R (VVVGARGVGK) Tetramer Protein, Human, MHC (His & Avi)
RASK2,CFC2,GTPase Kras,KRAS,K... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01525 |
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
CFC2,RALD,K-Ras 2,MHC,C-K-RAS,NS3,GTPase <... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01403 |
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (E. coli, His & Avi)
K-Ras 2,KI-RAS,CFC2,KRAS1,GTPase ... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01399 |
HLA-A*11:01&B2M&KRAS WT (VVGAGGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated
K-RAS2A,NS3,KRAS2,CFC2,K-RAS4B,GT... |
Human | E. coli |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. | |||
TMPK-01461 |
HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Monomer Protein, Human, MHC (His & Avi)
C-K-RAS,KRAS,RASK2,K-Ras... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
------------------------ 更多 ------------------------ |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIJ-0422 |
Benzo[k]fluoranthene-d12
|
||
Benzo[k]fluoranthene-d12 是 Benzo[k]fluoranthene 的氘代化合物。Benzo[k]fluoranthene 的 CAS 号为 207-08-9。 | |||
TMID-0302 |
Vitamin K3-d3
|
||
Vitamin K3-d3 是 Vitamin K3 的氘代化合物。Vitamin K3 的 CAS 号为 58-27-5。Menadione是合成的萘醌,能够在体内转化成活性维生素K2。 | |||
TMIH-0599 |
Vitamin K1-d7
|
||
Vitamin K1-d7 是 Vitamin K1 的氘代化合物。 | |||
TMIH-0600 |
Vitamin K3-d8
|
||
Vitamin K3-d8 是 Vitamin K3 的氘代化合物。 | |||
TMID-0001 |
Vitamin K1-d4
|
||
Vitamin K1-d4 是 Vitamin K1 的氘代化合物。Vitamin K1 的 CAS 号为 84-80-0。Vitamin K1 (Phylloquinone) 是天然存在的维生素。Vitamin K1是血液凝固,骨和血管代谢所必须的。 | |||
T40376 |
L-Phenylalanine-15N
L-苯丙氨酸 15N,(S)-2-Amino-3-phenylpropionic acid-15N,L-Phenylalanine-15N |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
L-Phenylalanine-15N ((S)-2-Amino-3-phenylpropionic acid-15N) 是 15N 标记的 L-Phenylalanine。L-Phenylalanine 是从大肠杆菌中分离出来的一种必需氨基酸。 L-Phenylalanine 广泛用于食品香精和药物的生产。 | |||
TMIJ-0074 |
Retigabine-d4
|
||
Retigabine-d4 是 Retigabine 的氘代化合物。Retigabine 的 CAS 号为 150812-12-7。Retigabine dihydrochloride 是一种抗惊厥药,用作有治疗经验的成年患者部分性癫痫的辅助治疗。作用机制涉及神经元 K(V)7.2-7.5(以前的 KCNQ2-5)电压激活 K(+) 通道的开放。 | |||
T12442 |
Phenindione D5
Rectadione D5,苯茚二酮 D5 |
Others | Others |
Phenindione D5 is deuterium labeled Phenindione, which functions as a Vitamin K antagonist. | |||
T10633 |
Bumetanide-d5
|
Others | Others |
Bumetanide D5 is a deuterium-labeled Bumetanide. Bumetanide is a Na+-K+-Cl- (NKCC1) inhibitor (IC50s: 0.68 and 4.0 μM for hNKCC1A and hNKCC2A). | |||
TMIH-0301 |
Levolansoprazole-d4
|
||
Levolansoprazole-d4 是 Levolansoprazole 的氘代化合物。Levolansoprazole 的 CAS 号为 138530-95-7。Levolansoprazole 是一种质子泵抑制剂,不可逆地抑制壁细胞中 H+/K+ 刺激的 ATPase 泵 (IC50: 5.2 µM)。它还抑制分离的犬壁细胞中的酸形成(IC50:82 µM)。 (R)-和 (S)-兰索拉唑均具有药理活性,具有相似的效力。 | |||
TMIH-0183 |
Dequalinium Chloride-d4
|
||
Dequalinium Chloride-d4 是 Dequalinium Chloride 的氘代化合物。Dequalinium Chloride 的 CAS 号为 522-51-0。Dequalinium chloride 是一种apamin敏感型的钾离子通道选择性阻断剂。 | |||
T37250 |
Cefazolin-13C2,15N
Cefazolin-13C2,15N |
||
Cefazolin-13C2,15N is intended for use as an internal standard for the quantification of cefazolin by GC- or LC-MS. Cefazolin is a broad-spectrum cephalosporin antibiotic that is active in vitro against various Gram-positive and Gram-negative bacteria (MICs = 0.2-12.5 μg/ml). It also inhibits the growth of clinical isolates of S. aureus, E. coli, P. mirabilis, and K. pneumoniae (MICs = 0.1-25 μg/ml). In vivo, cefazolin protects against S. aureus, E. coli, and P. mirabilis infection in mice (ED50... | |||
T73820 |
Bosentan-d4
|
||
Bosentan-d4 是 Bosentan 的氘代物。Bosentan 是一种有效的endothelin-1 (ET)拮抗剂,在人的 SMC 细胞中,作用于ETA 和ETB 受体,Ki 值分别为 4.7 nM 和 95 nM。 | |||
TMID-0040 |
Palmitoyl L-Carnitine-d3 Hydrochloride
|
||
Palmitoyl L-Carnitine-d3 Hydrochloride 是 Palmitoyl L-Carnitine Hydrochloride 的氘代化合物。Palmitoyl L-Carnitine Hydrochloride 的 CAS 号为 18877-64-0。L-Palmitoylcarnitine chloride (Palmitoyl-L-carnitine chloride)是一种脂肪酸代谢产物,具有抗血栓形成的作用,通过抵消tMCAO模型中的脑内血栓形成来保护小鼠免受缺血性中风。L-Palmitoylcarnitine chloride抑制心脏中的Na/K泵,抑制 FeCl 3诱导的动脉血栓形成,减轻了短暂性大脑中动脉闭塞(tMCAO)小鼠模型的脑内血栓形成和炎症。 | |||
TMID-0041 |
Menaquinone-9-d7
Vitamin K2-MK9-d7 |
||
Menaquinone-9-d7 是 Menaquinone-9 的氘代化合物。Menaquinone-9 的 CAS 号为 523-39-7。Menaquinone 9 (MK-9) 是一种维生素 K2 类似物,已在包括大肠杆菌在内的各种细菌中发现。Menaquinone 9 对紫外线敏感,可与细菌电子传输链的一种成分可溶性硝酸还原酶结合。 | |||
TMIJ-0138 |
Dronedarone-d6 HCl
|
||
Dronedarone-d6 HCl 是 Dronedarone HCl 的氘代化合物。Dronedarone HCl 的 CAS 号为 141625-93-6。Dronedarone Hydrochloride 是一种胺碘酮类似物,可抑制Na+,K+andCa2+的电流,有可能治疗心房颤动。 | |||
TMIJ-0503 |
Digoxin-d3
|
||
Digoxin-d3 是 Digoxin 的氘代化合物。Digoxin 的 CAS 号为 20830-75-5。Digoxin是Na+/K+-ATPase有效抑制剂,用于治疗各种心脏疾病。 | |||
TMIH-0469 |
Quinidine-d3
|
||
Quinidine-d3 是 Quinidine 的氘代化合物。Quinidine 的 CAS 号为 56-54-2。Quinidine 是一种抗心律失常剂,也是 K+通道的有效阻断剂,其IC50值为 19.9 μM。它是一种选择性细胞色素 P450db 的有效抑制剂,也可研究疟疾。 | |||
TMIH-0602 |
Vonoprazan-d4
|
||
Vonoprazan-d4 是 Vonoprazan 的氘代化合物。Vonoprazan 的 CAS 号为 881681-00-1。Vonoprazan 是一种质子泵抑制剂,是口服活性钾竞争性酸阻断剂,有抗分泌作用。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50值为 19 nM。它可用于研究胃酸相关疾病。 | |||
TMIH-0601 |
Vonoprazan-d3
|
||
Vonoprazan-d3 是 Vonoprazan 的氘代化合物。Vonoprazan 的 CAS 号为 881681-00-1。Vonoprazan 是一种质子泵抑制剂,是口服活性钾竞争性酸阻断剂,有抗分泌作用。在 pH 为 6.5 时,它抑制猪胃微粒体中的 H+,K+-ATPase 酶活性,IC50值为 19 nM。它可用于研究胃酸相关疾病。 | |||
TMIJ-0192 |
Pantoprazole-d6
|
||
Pantoprazole-d6 是 Pantoprazole 的氘代化合物。Pantoprazole 的 CAS 号为 102625-70-7。Pantoprazole 是一种质子泵抑制剂,用于短期治疗由胃食管反流病引起的食管糜烂和溃疡。它联合阿霉素可显著增加肿瘤生长延迟。它是一种取代的苯并咪唑,是H+/K+-ATPase抑制剂,可改善 pH 值稳定性,具有抗分泌和抗溃疡的作用。 | |||
TMIH-0222 |
Esomeprazole sodium-d6
|
||
Esomeprazole sodium-d6 是 Esomeprazole sodium 的氘代化合物。Esomeprazole sodium 的 CAS 号为 161796-78-7。Esomeprazole sodium 是一种口服有效的活性质子泵抑制剂。Esomeprazole sodium通过抑制胃壁细胞中的H+, K+-ATPase来降低酸分泌,在胃食管反流疾病中有研究价值。Esomeprazole 是一种外泌体抑制剂,通过抑制 V-H+-ATPases 来阻断外泌体的释放。 | |||
T35789 |
Palmitic acid-1-13C
|
||
Palmitic acid-13C is intended for use as an internal standard for the quantification of palmitic acid by GC- or LC-MS. Palmitic acid is a 16-carbon saturated fatty acid. It comprises approximately 25% of human total plasma lipids.1 It increases protein levels of COX-2 in RAW 264.7 cells when used at a concentration of 75 μM.2 Palmitic acid is involved in the acylation of proteins to anchor membrane-bound proteins to the lipid bilayer.2,3,4,5,6 |1. Santos, M.J., López-Jurado, M., Llopis, J., et a... | |||
T35591 |
Guanfacine-13C,15N3
Guanfacine-13C,15N3 |
||
Guanfacine-13C,15N3is intended for us as an internal standard for the quantification of guanfacine by GC- or LC-MS. Guanfacine is an α2-adrenergic receptor (α2-AR) agonist with Kivalues of 93, 1,380, and 3,890 nM for α2A-, α2B-, and α2C-ARs, respectively, in a radioligand binding assay.1It has EC50values of 52, 288, and 602 nM for α2A-, α2B-, and α2C-ARs, respectively, for stimulated [35S]GTPγS binding. It also binds to imidazoline receptor 1 (Ki= 19 nM in a radioligand binding assay).2Guanfacin... | |||
T36055 |
Nitisinone-13C6
Nitisinone-13C6 |
||
Nitisinone-13C6is intended for use as an internal standard for the quantification of nitisinone by GC- or LC-MS. Nitisinone is an inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), which converts 4-hydroxyphenylpyruvate (HPPA) to homogentisate in the tyrosine catabolic pathway.1Nitisinone increases urinary levels of HPPA and 4-hydroxyphenyllactate (HPLA) in rats when administered at a dose of 10 mg/kg. Nitisinone (3 mg/kg) prevents the neonatal lethality of fumarylacetoacetate hydrolase (F... | |||
T35791 |
Palmitic acid-13C
|
||
Palmitic acid-13C is intended for use as an internal standard for the quantification of palmitic acid by GC- or LC-MS. Palmitic acid-13C contains 13C at the C2 position and has been used in the study of free fatty acid incorporation into phospholipid fatty acids in soil microbes.1 Palmitic acid is a 16-carbon saturated fatty acid. It comprises approximately 25% of human total plasma lipids.2 It increases protein levels of COX-2 in RAW 264.7 cells when used at a concentration of 75 μM.3 Palmitic ... | |||
T37847 |
Zonisamide-13C2,15N
Zonisamide-13C2,15N |
||
Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium... |